Key result
Higher pre-intervention CRP linked to greater risk of femoropopliteal artery restenosis.
Why the study?
Elevated pre-intervention CRP is linked to coronary restenosis, but its association with femoropopliteal artery restenosis remains unclear.
Are elevated pre-endovascular intervention CRP levels associated with increased risk of femoropopliteal artery restenosis?
Meta-Analysis (n=2,097)
Are elevated pre-endovascular intervention CRP levels associated with increased risk of femoropopliteal artery restenosis?
Effect estimate: SMD 0.44 (95% CI 0.09-0.78)
p-value: p=0.01
Elevated pre-procedural CRP levels are significantly associated with an increased risk of femoropopliteal artery restenosis following endovascular intervention.
Preprocedural CRP may stratify restenosis risk before femoropopliteal intervention; leaves open causality and value of anti-inflammatory therapies.
ABSTRACT Introduction Restenosis in previously treated femoral or popliteal arteries remains a clinical issue, leading to repeat procedures, and major adverse limb events. Elevated pre-endovascular intervention levels of C-reactive protein (CRP), a marker of systemic inflammation, have previously been associated with coronary restenosis, however, its association with femoropopliteal artery restenosis is unclear. We conducted a systematic review and study-level meta-analysis to assess the association between pre-endovascular intervention CRP levels and femoropopliteal artery restenosis. Methods Online databases of PubMed, EMBASE, MEDLINE (OVID), Scopus and Web of Science were searched for relevant articles published until September 30th, 2025. A Z-test using a random effects model was used to pool study-level results to obtain pooled standardized mean differences (SMD) and its 95% confidence intervals (CI). A p value of <0.05 indicated statistical significance. Results After screening a total of 331 unique articles, 14 studies, including 2,097 patients (562 restenosis cases/1,535 no-restenosis controls) were available for quantitative synthesis. Pooled results suggested a significant association between higher pre-endovascular intervention CRP levels and femoropopliteal artery restenosis. (SMD= 0.44, 95% Cl, 0.09-0.78, p=0.01). There was no evidence of publication bias, both visually via Begg's funnel plot and statistically via Egger's test results (p= 0.52). Leave-one-out sensitivity analysis supported the robustness of the pooled results. Conclusions This systematic review and study-level meta-analysis suggests a significant association between higher pre-endovascular intervention CRP levels and the subsequent development of femoropopliteal artery restenosis. Our findings should be interpreted with caution and further large-scale prospective investigations are warranted to substantiate our results.
No takes yet. Share an insight, caveat, or question.
Pasha et al. (2026) conducted a meta-analysis in Femoropopliteal artery disease (n=2,097). Higher pre-endovascular intervention C-reactive protein (CRP) levels vs. Lower CRP levels was evaluated on Femoropopliteal artery restenosis (SMD 0.44, 95% CI 0.09-0.78, p=0.01). Higher pre-endovascular intervention C-reactive protein levels were significantly associated with the subsequent development of femoropopliteal artery restenosis (SMD 0.44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: